Bayer lapse exposes pharma's vulnerability.
Hodgson, J
Bayer lapse exposes pharma's vulnerability. [electronic resource] - Nature biotechnology Oct 2001 - 897-8 p. digital
Publication Type: News
1087-0156
10.1038/nbt1001-897b doi
Anticholesteremic Agents--adverse effects
Drug Industry
Humans
Product Surveillance, Postmarketing
Pyridines--adverse effects
Research
Rhabdomyoma--chemically induced
Bayer lapse exposes pharma's vulnerability. [electronic resource] - Nature biotechnology Oct 2001 - 897-8 p. digital
Publication Type: News
1087-0156
10.1038/nbt1001-897b doi
Anticholesteremic Agents--adverse effects
Drug Industry
Humans
Product Surveillance, Postmarketing
Pyridines--adverse effects
Research
Rhabdomyoma--chemically induced